Evaluation of Ministry of Health, Labour and Welfare diagnostic criteria for antineutrophil cytoplasmic antibody-associated vasculitis compared to ACR/EULAR 2022 classification criteria

被引:2
|
作者
Sada, Ken-ei [1 ,2 ,18 ]
Nagasaka, Kenji [3 ,4 ]
Kaname, Shinya [5 ]
Higuchi, Tomoaki [6 ,7 ]
Furuta, Shunsuke [8 ]
Nanki, Toshihiro [9 ]
Tsuboi, Naotake [10 ]
Amano, Koichi [11 ]
Dobashi, Hiroaki [12 ]
Hiromura, Keiju [13 ]
Bando, Masashi [14 ]
Wada, Takashi [15 ]
Arimura, Yoshihiro [5 ,16 ]
Makino, Hirofumi [17 ]
Harigai, Masayoshi [7 ]
机构
[1] Kochi Med Sch, Dept Clin Epidemiol, Nankoku, Japan
[2] Okayama Univ, Dept Nephrol Rheumatol Endocrinol & Metab, Grad Sch Med Dent & Pharmaceut Sci, Okayama, Japan
[3] Ome Municipal Gen Hosp, Dept Rheumatol, Ome, Japan
[4] Tokyo Med & Dent Univ, Dept Rheumatol, Tokyo, Japan
[5] Kyorin Univ, Dept Nephrol & Rheumatol, Sch Med, Tokyo, Japan
[6] Tokyo Womens Med Univ, Div Multidisciplinary Management Rheumat Dis, Sch Med, Tokyo, Japan
[7] Tokyo Womens Med Univ, Dept Internal Med, Div Rheumatol, Sch Med, Tokyo, Japan
[8] Chiba Univ, Dept Allergy & Clin Immunol, Chiba, Japan
[9] Toho Univ, Dept Internal Med, Div Rheumatol, Sch Med, Tokyo, Japan
[10] Fujita Hlth Univ, Grad Sch Med, Dept Nephrol, Toyoake, Aichi, Japan
[11] Saitama Med Univ, Saitama Med Ctr, Dept Rheumatol & Clin Immunol, Kawagoe, Saitama, Japan
[12] Kagawa Univ, Fac Med, Dept Internal Med, Div Hematol Rheumatol & Resp Med, Kagawa, Japan
[13] Gunma Univ, Dept Nephrol & Rheumatol, Grad Sch Med, Maebashi, Gumma, Japan
[14] Jichi Med Univ, Dept Med, Div Pulm Med, Shimotsuke, Tochigi, Japan
[15] Kanazawa Univ, Kanazawa, Japan
[16] Kichijoji Asahi Hosp, Musashino, Japan
[17] Okayama Univ, Okayama, Japan
[18] Kochi Med Sch, Dept Clin Epidemiol, Oko Cho, Nankoku, Kochi 7838505, Japan
关键词
Antineutrophil cytoplasmic antibody; classification criteria; eosinophilic granulomatosis with polyangiitis; granulomatosis with polyangiitis; microscopic polyangiitis; AMERICAN-COLLEGE; RHEUMATOLOGY/EUROPEAN ALLIANCE; EOSINOPHILIC GRANULOMATOSIS;
D O I
10.1093/mr/road052
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective This study aimed to evaluate the Ministry of Health, Labour and Welfare (MHLW) diagnostic criteria for antineutrophil cytoplasmic antibody-associated vasculitis compared to the new American College of Rheumatology/European Alliance of Associations for Rheumatology 2022 criteria. Methods Two nationwide cohort studies were used, and participants were categorised as having eosinophilic granulomatosis with polyangiitis, granulomatosis with polyangiitis (GPA), or microscopic polyangiitis (MPA) according to the American College of Rheumatology/European Alliance of Associations for Rheumatology 2022 and MHLW criteria. Results Of the entire patient population, only 10 (2.1%) were unclassifiable according to the MHLW probable criteria, while a significant number of patients (71.3%) met at least two criteria. The MHLW probable criteria for MPA had some challenges in differentiating between MPA and eosinophilic granulomatosis with polyangiitis, and the same was true for MHLW probable criteria for GPA in differentiating MPA from GPA. Nevertheless, improved classification results were obtained when the MHLW probable criteria were applied in the order of eosinophilic granulomatosis with polyangiitis, MPA, and GPA. Conclusions The application of MHLW criteria could categorise a substantial number of patients with antineutrophil cytoplasmic antibody-associated vasculitis into one of the three antineutrophil cytoplasmic antibody-associated vasculitis diseases. The classification was in accordance with the American College of Rheumatology/European Alliance of Associations for Rheumatology 2022 criteria when considering the order of application.
引用
收藏
页码:551 / 558
页数:8
相关论文
共 50 条
  • [21] ACR/EULAR-endorsed study to develop Diagnostic and Classification Criteria for Vasculitis (DCVAS)
    Anthea Craven
    Joanna Robson
    Cristina Ponte
    Peter C. Grayson
    Ravi Suppiah
    Andrew Judge
    Richard Watts
    Peter A. Merkel
    Raashid A. Luqmani
    Clinical and Experimental Nephrology, 2013, 17 : 619 - 621
  • [22] Evaluation of the ACR/EULAR 2022 criteria for classification of ANCA-associated vasculitis in a population-based cohort from Sweden
    Rathmann, Jens
    Segelmark, Marten
    Mohammad, Aladdin J.
    RHEUMATOLOGY, 2023, : 1965 - 1972
  • [23] Evaluation of the ACR/EULAR 2022 criteria for classification of ANCA-associated vasculitis in a population-based cohort from Sweden
    Rathmann, Jens
    Segelmark, Marten
    Mohammad, Aladdin J.
    RHEUMATOLOGY, 2023, 63 (07) : 1965 - 1972
  • [24] EVALUATION OF THE OF THE 2022 ACR/EULAR CLASSIFICATION CRITERIA FOR GCA IN A GERMAN PATIENT COHORT
    Bergner, R.
    Schulz, P.
    Friedrich, J.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1555 - 1556
  • [25] Evaluation of the Validity of the 2022 American College of Rheumatology/European Alliance of Associations for Rheumatology Classification Criteria for Antineutrophil Cytoplasmic Antibody-associated Vasculitis for an Asian Population on the Basis of the Patterns of Organ Involvement
    Kuwata, Ryo
    Shirota, Yuko
    Shirai, Tsuyoshi
    Yamashita, Hiroyuki
    Sato, Hiroko
    Oka, Yumiko
    Kodera, Takao
    Motomura, Kyoko
    Kaneko, Hiroshi
    Kameoka, Junichi
    Fujii, Hiroshi
    Ishii, Tomonori
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 3035 - 3038
  • [26] COMPARISON OF THE NEW ACR/EULAR CLASSIFICATION CRITERIA OF ANCA-ASSOCIATED VASCULITIS WITH THE EMA ALGORITHM IN CLASSIFICATION OF VASCULITIS
    Li, S.
    Zhang, Q.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 1492 - 1492
  • [27] Incidence of Malignancy Prior to Antineutrophil Cytoplasmic Antibody-associated Vasculitis Compared to the General Population
    van Daalen, Emma E.
    Rahmattulla, Chinar
    Wolterbeek, Ron
    Bruijn, Jan A.
    Bajema, Ingeborg M.
    JOURNAL OF RHEUMATOLOGY, 2017, 44 (03) : 314 - 318
  • [28] Comment on: Evaluation of the ACR/EULAR 2022 criteria for classification of ANCA-associated vasculitis in a population-based cohort from Sweden
    Khan, Sujoy
    RHEUMATOLOGY, 2024,
  • [29] The impact of reclassification by the 2022 ACR/EULAR classification criteria on risk factors for relapse in patients with ANCA-associated vasculitis
    van Leeuwen, Jolijn R.
    Hafemann, Sophia
    van der Boog, Paul
    van der Woude, Diane
    Rabelink, Ton
    Teng, Y. K. Onno
    CLINICAL KIDNEY JOURNAL, 2023, 16 (12) : 2754 - 2756
  • [30] The confused puzzles in antineutrophil cytoplasmic antibody-associated vasculitis activity evaluation: A case report
    Zhang, Ai-hua
    Yao, Wei-long
    Liu, Wen-hu
    CLINICAL CASE REPORTS, 2021, 9 (07):